217 related articles for article (PubMed ID: 10760436)
21. Carboplatin as a potentiator of radiation therapy.
Douple EB; Richmond RC; O'Hara JA; Coughlin CT
Cancer Treat Rev; 1985 Sep; 12 Suppl A():111-24. PubMed ID: 3910216
[TBL] [Abstract][Full Text] [Related]
22. Carboplatin enhances the production and persistence of radiation-induced DNA single-strand breaks.
Yang LX; Douple EB; O'Hara JA; Wang HJ
Radiat Res; 1995 Sep; 143(3):302-8. PubMed ID: 7652168
[TBL] [Abstract][Full Text] [Related]
23. Evidence for the induction of two types of potentially lethal damage after exposure of plateau phase Chinese hamster V79 cells to gamma-rays.
Iliakis G
Radiat Environ Biophys; 1985; 24(3):185-202. PubMed ID: 4034924
[TBL] [Abstract][Full Text] [Related]
24. DNA effects in repair-deficient V79 Chinese hamster cells studied with the comet assay.
Helbig R; Speit G
Mutat Res; 1997 Jul; 377(2):279-86. PubMed ID: 9247625
[TBL] [Abstract][Full Text] [Related]
25. Intracellular metabolism of the orally active platinum drug JM216: influence of glutathione levels.
Raynaud FI; Odell DE; Kelland LR
Br J Cancer; 1996 Aug; 74(3):380-6. PubMed ID: 8695352
[TBL] [Abstract][Full Text] [Related]
26. Enhancement of radiation effects in vitro by the estrogen metabolite 2-methoxyestradiol.
Amorino GP; Freeman ML; Choy H
Radiat Res; 2000 Apr; 153(4):384-91. PubMed ID: 10760997
[TBL] [Abstract][Full Text] [Related]
27. DNA-binding properties of novel cis- and trans platinum-based anticancer agents in 2 human ovarian carcinoma cell lines.
Mellish KJ; Barnard CF; Murrer BA; Kelland LR
Int J Cancer; 1995 Sep; 62(6):717-23. PubMed ID: 7558420
[TBL] [Abstract][Full Text] [Related]
28. Enhancement of radiosensitivity of cultured mammalian cells by neocarzinostatin. I. Inhibition of the repair of sublethal damage.
Antoku S; Kura S
Int J Radiat Biol; 1990 Oct; 58(4):613-22. PubMed ID: 1976722
[TBL] [Abstract][Full Text] [Related]
29. Characterization of an X-ray-hypersensitive mutant of V79 Chinese hamster cells.
Zdzienicka MZ; Tran Q; van der Schans GP; Simons JW
Mutat Res; 1988 Nov; 194(3):239-49. PubMed ID: 2460764
[TBL] [Abstract][Full Text] [Related]
30. Radiosensitizing properties of novel hydroxydicarboxylatoplatinum(II) complexes with high or low reactivity with thiols: two modes of action.
Gradzka I; Buraczewska I; Kuduk-Jaworska J; Romaniewska A; Szumiel I
Chem Biol Interact; 2003 Oct; 146(2):165-77. PubMed ID: 14597130
[TBL] [Abstract][Full Text] [Related]
31. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of satraplatin (JM216), an oral platinum (IV) complex under daily oral administration for 5 or 14 days.
Vouillamoz-Lorenz S; Buclin T; Lejeune F; Bauer J; Leyvraz S; Decosterd LA
Anticancer Res; 2003; 23(3C):2757-65. PubMed ID: 12926110
[TBL] [Abstract][Full Text] [Related]
33. Selective potentiation of platinum drug cytotoxicity in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines by amphotericin B.
Sharp SY; Mistry P; Valenti MR; Bryant AP; Kelland LR
Cancer Chemother Pharmacol; 1994; 35(2):137-43. PubMed ID: 7987990
[TBL] [Abstract][Full Text] [Related]
34. Ku86 modulates DNA topoisomerase I-mediated radiosensitization, but not cytotoxicity, in mammalian cells.
Shih SJ; Erbele T; Chen AY
Cancer Res; 2005 Oct; 65(20):9194-9. PubMed ID: 16230379
[TBL] [Abstract][Full Text] [Related]
35. Different accumulation of cisplatin, oxaliplatin and JM216 in sensitive and cisplatin-resistant human cervical tumour cells.
Martelli L; Di Mario F; Ragazzi E; Apostoli P; Leone R; Perego P; Fumagalli G
Biochem Pharmacol; 2006 Sep; 72(6):693-700. PubMed ID: 16844093
[TBL] [Abstract][Full Text] [Related]
36. Tumoricidal interactions of hyperthermia with carboplatin, cisplatin and etoposide.
Cohen JD; Robins HI; Schmitt CL
Cancer Lett; 1989 Mar; 44(3):205-10. PubMed ID: 2647285
[TBL] [Abstract][Full Text] [Related]
37. Production of DNA double-strand breaks by interactions between carboplatin and radiation: a potential mechanism for radiopotentiation.
Yang LX; Douple EB; O'Hara JA; Wang HJ
Radiat Res; 1995 Sep; 143(3):309-15. PubMed ID: 7652169
[TBL] [Abstract][Full Text] [Related]
38. Effects of cis-platinum(II) diamminedichloride on survival and the rate of DNA synthesis in synchronously growing Chinese hamster V79-379A cells in the absence and presence of caffeine inhibited post-replication repair; evidence for an inducible repair mechanism.
Fraval HN; Roberts JJ
Chem Biol Interact; 1978 Oct; 23(1):99-110. PubMed ID: 699192
[TBL] [Abstract][Full Text] [Related]
39. Ku-dependent non-homologous end-joining as the major pathway contributes to sublethal damage repair in mammalian cells.
Liu M; Lee S; Liu B; Wang H; Dong L; Wang Y
Int J Radiat Biol; 2015; 91(11):867-871. PubMed ID: 26189733
[TBL] [Abstract][Full Text] [Related]
40. In vitro enhancement of tumor cell radiosensitivity by a selective inhibitor of cyclooxygenase-2 enzyme: mechanistic considerations.
Raju U; Nakata E; Yang P; Newman RA; Ang KK; Milas L
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):886-94. PubMed ID: 12377342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
